GAMMAKED

Indicated For

Primary Immunodeficiency (PI), Idiopathic Thrombocytopenic Purpura (ITP), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

About This Medication

# GAMMAKED Patient Guide: How to Get GAMMAKED at Low or No Cost GAMMAKED (immune globulin injection (human) 10% caprylate/chromatography purified) is a vital treatment for certain immune disorders, and Kedrion Biopharma offers a **Co-Pay Assistance Program** to help eligible patients reduce out-of-pocket costs.[1][2] This guide explains eligibility, application steps, and more in simple terms to empower you in accessing this therapy affordably. ## About GAMMAKED GAMMAKED is an intravenous immune globulin (IVIG) therapy made from human plasma, purified to 10% concentration using caprylate and chromatography processes.[1][7] It provides antibodies to help your immune system fight infections and manage specific conditions. **Approved uses include:** - **Primary Humoral Immunodeficiency (PI)**: Replacement therapy for patients 2 years and older to prevent infections.[1][7] - **Idiopathic Thrombocytopenic Purpura (ITP)**: In adults and children to raise platelet counts and prevent bleeding.[1][7] - **Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)**: In adults to improve nerve function and prevent relapses.[1][7] It's administered via IV infusion, with dosing tailored by your doctor—for example, 300-600 mg/kg every 3-4 weeks for PI, or higher loading doses for CIDP.[8][9] Always follow your healthcare provider's instructions, as GAMMAKED carries risks like allergic reactions, kidney issues, or blood clots—discuss these with your doctor.[1][8] ## Who Qualifies for Assistance? Kedrion Biopharma's **GAMMAKED Co-Pay Assistance Program** targets **commercially insured patients** facing high co-pays or deductibles.[1][2][4] Key requirements: - **Commercial insurance** only—no government programs like Medicare, Medicaid, VA, or Tricare.[1][2] - **Financial need**: You must demonstrate out-of-pocket costs are a burden (e.g., high co-pays for GAMMAKED).[1][2] - **Approved conditions**: PI, ITP, or CIDP only.[1][2] **No free drug program** is explicitly detailed for uninsured patients in available resources, but Kedrion's Customer Service (1-855-353-7466) can assist with insurance verification, prior authorizations, or denials—potentially linking to other options.[3] Uninsured or underinsured patients may explore general IVIG assistance via provider referrals.[3] ## Income Eligibility Breakdown This program does **not use strict federal poverty level (FPL) thresholds** like some patient assistance programs. Instead, eligibility hinges on **commercial insurance**, **financial need expression**, and **treatment indication**.[1][2] No specific income caps (e.g., 400% FPL) are listed; decisions are case-by-case based on your situation. | Household Size | Income Threshold | Notes | |---------------|------------------|-------| | Individual | Not specified (financial need required) | Commercial insurance mandatory; government insurance disqualifies.[1][2] | | Couple | Not specified (financial need required) | Assistance for co-pays on pharmacy/medical benefits.[1][2] | | Family of 3 | Not specified (financial need required) | PI, ITP, CIDP only.[1][2] | | Family of 4 | Not specified (financial need required) | Contact Kedrion for personalized review.[3] | If uninsured, call Kedrion Customer Service for potential alternatives, as some IG products offer free medication to qualified uninsured patients.[3] ## Insurance Requirements **Commercial insurance is required**—covering GAMMAKED under pharmacy or medical benefits.[1][2] **Government-funded insurance disqualifies you**, including: - Medicare, Medicaid, Medigap - VA, DoD, Tricare[1][2] Your plan must prescribe GAMMAKED for an approved use. Kedrion helps with prior authorizations and claim denials via 1-855-353-7466.[3] ## Step-by-Step Application Process 1. **Confirm Eligibility**: Verify commercial insurance, financial need, and diagnosis (PI, ITP, or CIDP) with your doctor.[1][2] 2. **Gather Documents**: Prescription, proof of insurance, income details (e.g., tax returns, pay stubs) to show need. Exact list not specified—call for details.[3] 3. **Contact Kedrion**: Call **1-855-353-7466** (Ext. 4 for assistance) or visit gammaked.com/patient-resources for co-pay program info.[1][3] 4. **Submit Application**: Likely via phone, provider portal, or online form (details at Kedrion site). Your doctor may need to enroll you.[2][4] 5. **Approval Wait**: Processing time not specified—expect days to weeks; follow up promptly.[3] 6. **Receive Benefits**: Co-pay cards or direct support applied at pharmacy/infusion center.[1] Have your doctor call if needed for support.[3] ## Timeline and Delivery **Processing time**: Not explicitly stated; similar programs approve in 1-2 weeks, but call 1-855-353-7466 for updates.[3] **Delivery**: GAMMAKED is dispensed via specialty pharmacies, home infusion, or clinics in Kedrion's network.[5] Co-pay help reduces costs at point-of-service—no direct shipping mentioned.[1] Infusions occur as prescribed (e.g., every 3 weeks), with rates starting slow (1-2 mg/kg/min) to minimize risks.[8][9] ## Alternatives if Denied or Ineligible - **Switch Insurance/Pharmacy**: Ask about in-network options or 340B programs via contract pharmacies.[5] - **Other IVIG Brands**: Programs like Grifols (Gamunex-C, 888-694-2686) or Takeda (Gammagard, 888-229-8379) for uninsured/underinsured.[3] - **General Assistance**: PAN Foundation, HealthWell Foundation, or state programs for immune disorders. - **Manufacturer Support**: Kedrion for prior auth help or claim appeals.[3] - **No Biosimilars**: None listed for GAMMAKED.[ ] ## Important Disclaimer This guide is for informational purposes based on publicly available data as of 2026 and is **not medical or financial advice**.[1][2] Programs change—**always verify with Kedrion Biopharma (1-855-353-7466) or gammaked.com**. Consult your doctor before starting GAMMAKED. Kedrion/gammaked.com not liable for application outcomes. Word count: 1027.

Program information last verified: March 30, 2026